[stock_market_widget type="clock-markets" template="analog" timezone="America/New_York" title="New York" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Europe/London" title="London" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Europe/Brussels" title="Brussels" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Asia/Hong_Kong" title="Hong Kong" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Asia/Tokyo" title="Tokyo" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Australia/Sydney" title="Sydney" style="font-size: 7px; width: 100px;"]

Stock Market News

US House panel to hold hearing with pharmacy benefit managers on healthcare costs

07/17/2024

Less than a minute

2024.07.17 10:05

WASHINGTON (Reuters) – The U.S. House of Representatives oversight panel said on Tuesday it will hold a hearing with executives from U.S. pharmacy benefit managers on the role of the firms in rising healthcare costs.

The hearing will include Adam Kautzner, president of Evernorth Care Management and Express Scripts; David Joyner, executive vice president of CVS Health (NYSE:) and president of CVS Caremark; and Patrick Conway, CEO of OptumRx, the panel’s chair, Representative James Comer, a Republican, said in a statement.

The hearing is set for July 23.

Source link

07/17/2024

Less than a minute